Literature DB >> 25963482

Effect of Intramuscular Adipose Tissue Content on Prognosis in Patients Undergoing Hepatocellular Carcinoma Resection.

Masaki Kaibori1, Morihiko Ishizaki, Hiroya Iida, Kosuke Matsui, Tatsuma Sakaguchi, Kentaro Inoue, Toshihiko Mizuta, Yasushi Ide, Junji Iwasaka, Yutaka Kimura, Fumikazu Hayashi, Daiki Habu, Masanori Kon.   

Abstract

BACKGROUND: It has recently been reported that myosteatosis, the infiltration of fat in skeletal muscle, is associated with insulin resistance and type 2 diabetes mellitus. The present study investigated the effect of skeletal muscle fat accumulation on short- and long-term outcomes following partial hepatectomy for hepatocellular carcinoma (HCC) and aimed to identify prognostic factors.
METHODS: The records of 141 HCC patients who underwent hepatectomy were retrospectively reviewed. Clinicopathological and outcome data from 71 patients with high intramuscular adipose tissue content (IMAC) were compared with those from 70 patients with low IMAC.
RESULTS: The 5-year overall survival rate was 46% among patients with high IMAC and 75% among those with low IMAC. The 5-year disease-free survival rates in these groups were 18 and 38%, respectively. Multivariate analysis revealed that high IMAC was predictive of an unfavorable prognosis. High IMAC was significantly correlated with liver dysfunction, higher intraoperative blood loss, the need for blood transfusion, and comorbid diabetes mellitus.
CONCLUSIONS: Greater fat accumulation in skeletal muscle was predictive of worse overall survival after partial hepatectomy in patients with HCC, even with adjustment for other known predictors. The identification of patients with greater skeletal muscle fat accumulation before hepatectomy could permit early preventive strategies to maintain muscle quality and thus improve prognosis and patient selection for hepatectomy.

Entities:  

Mesh:

Year:  2015        PMID: 25963482     DOI: 10.1007/s11605-015-2838-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  44 in total

1.  Major achievements in hepatocellular carcinoma.

Authors:  Jordi Bruix; Josep M Llovet
Journal:  Lancet       Date:  2009-02-21       Impact factor: 79.321

Review 2.  Is liver disease a threat to patients with metabolic disorders?

Authors:  Giulio Marchesini; Gabriele Forlani; Elisabetta Bugianesi
Journal:  Ann Med       Date:  2005       Impact factor: 4.709

3.  Skeletal muscle triglyceride levels are inversely related to insulin action.

Authors:  D A Pan; S Lillioja; A D Kriketos; M R Milner; L A Baur; C Bogardus; A B Jenkins; L H Storlien
Journal:  Diabetes       Date:  1997-06       Impact factor: 9.461

4.  Muscle wasting is associated with mortality in patients with cirrhosis.

Authors:  Aldo J Montano-Loza; Judith Meza-Junco; Carla M M Prado; Jessica R Lieffers; Vickie E Baracos; Vincent G Bain; Michael B Sawyer
Journal:  Clin Gastroenterol Hepatol       Date:  2011-09-03       Impact factor: 11.382

5.  Insulin promotion of colon tumors in rats.

Authors:  T T Tran; A Medline; W R Bruce
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-12       Impact factor: 4.254

6.  Oxidative stress EPR measurement in human liver by radical-probe technique. Correlation with etiology, histology and cell proliferation.

Authors:  Marco Valgimigli; Luca Valgimigli; Davide Trerè; Stefano Gaiani; Gian Franco Pedulli; Laura Gramantieri; Luigi Bolondi
Journal:  Free Radic Res       Date:  2002-09

Review 7.  Lipid and lipoprotein dysregulation in insulin resistant states.

Authors:  Rita Kohen Avramoglu; Heather Basciano; Khosrow Adeli
Journal:  Clin Chim Acta       Date:  2006-02-09       Impact factor: 3.786

8.  Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life.

Authors:  I J Hickman; J R Jonsson; J B Prins; S Ash; D M Purdie; A D Clouston; E E Powell
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

9.  Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis.

Authors:  Yusuke Kawamura; Kenji Ikeda; Yasuji Arase; Hiromi Yatsuji; Hitomi Sezaki; Tetsuya Hosaka; Norio Akuta; Masahiro Kobayashi; Satoshi Saitoh; Fumitaka Suzuki; Yoshiyuki Suzuki; Hiromitsu Kumada
Journal:  J Gastroenterol Hepatol       Date:  2008-08-17       Impact factor: 4.029

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  14 in total

1.  Association between low preoperative skeletal muscle quality and infectious complications following gastrectomy for gastric cancer.

Authors:  Tsuneyuki Uchida; Ryuichi Sekine; Kenichi Matsuo; Gaku Kigawa; Takahiro Umemoto; Kazuhiro Kijima; Yoshikuni Harada; Tetsuji Wakabayashi; Yuki Takahashi; Toshimitsu Shiozawa; Hideyuki Oyama; Shiori Shibata; Kuniya Tanaka
Journal:  Surg Today       Date:  2021-01-25       Impact factor: 2.549

2.  The Impact of Myosteatosis Percentage on Short-Term Mortality in Patients with Septic Shock.

Authors:  June-Sung Kim; Jiyeon Ha; Youn-Jung Kim; Yousun Ko; Taeyong Park; Kyung Won Kim; Won Young Kim
Journal:  J Clin Med       Date:  2022-05-27       Impact factor: 4.964

Review 3.  Update on perioperative management of patients undergoing surgery for liver cancer.

Authors:  Masaki Kaibori; Kosuke Matsui; Mitsuo Shimada; Shoji Kubo; Kiyoshi Hasegawa
Journal:  Ann Gastroenterol Surg       Date:  2021-12-15

4.  Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer.

Authors:  David P J van Dijk; Maikel J A M Bakens; Mariëlle M E Coolsen; Sander S Rensen; Ronald M van Dam; Martijn J L Bours; Matty P Weijenberg; Cornelis H C Dejong; Steven W M Olde Damink
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-10-26       Impact factor: 12.910

Review 5.  Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact.

Authors:  Hiroki Nishikawa; Hirayuki Enomoto; Shuhei Nishiguchi; Hiroko Iijima
Journal:  Int J Mol Sci       Date:  2021-02-15       Impact factor: 5.923

6.  Various myosteatosis selection criteria and their value in the assessment of short- and long-term outcomes following liver transplantation.

Authors:  Franziska Alexandra Meister; Jan Bednarsch; Iakovos Amygdalos; Joerg Boecker; Pavel Strnad; Philipp Bruners; Sven Arke Lang; Tom Florian Ulmer; Lara Heij; Daniel Antonio Morales Santana; Wen-Jia Liu; Georg Lurje; Ulf Peter Neumann; Zoltan Czigany
Journal:  Sci Rep       Date:  2021-06-28       Impact factor: 4.379

Review 7.  ERAS: Improving outcome in the cachectic HPB patient.

Authors:  David P J van Dijk; Victor van Woerden; Hamit Cakir; Marcel den Dulk; Steven W M Olde Damink; Cornelis H C Dejong
Journal:  J Surg Oncol       Date:  2017-08-02       Impact factor: 3.454

8.  Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas.

Authors:  Cynthia Stretch; Jean-Michel Aubin; Beata Mickiewicz; Derek Leugner; Tariq Al-Manasra; Elizabeth Tobola; Santiago Salazar; Francis R Sutherland; Chad G Ball; Elijah Dixon; Hans J Vogel; Sambasivario Damaraju; Vickie E Baracos; Oliver F Bathe
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

Review 9.  New Insights into the Liver-Visceral Adipose Axis During Hepatic Resection and Liver Transplantation.

Authors:  María Eugenia Cornide-Petronio; Mónica B Jiménez-Castro; Jordi Gracia-Sancho; Carmen Peralta
Journal:  Cells       Date:  2019-09-18       Impact factor: 6.600

10.  Impact of preoperative muscle quality on postoperative severe complications after radical gastrectomy for gastric cancer patients.

Authors:  Ryota Matsui; Noriyuki Inaki; Toshikatsu Tsuji
Journal:  Ann Gastroenterol Surg       Date:  2021-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.